94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Natasha Irrera1
Vincenzo Arcoraci1
Federica Mannino1
Giovanna Vermiglio2
Giovanni Pallio1
Letteria Minutoli1
Gianluca Bagnato3Giuseppe Pio Anastasi2
Emanuela Mazzon4
Placido Bramanti4
Francesco Squadrito1*
Domenica Altavilla2
Alessandra Bitto1- 1Department of Clinical and Experimental Medicine, AOU Policlinico G. Martino, University of Messina, Messina, Italy
- 2Department of Biomedical and Dental Sciences and Morphological and Functional Sciences, AOU Policlinico G. Martino, University of Messina, Messina, Italy
- 3NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom
- 4IRCCS Centro Neurolesi “Bonino-Pulejo”, Messina, Italy
A Corrigendum on
Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury
by Irrera N, Arcoraci V, Mannino F, Vermiglio G, Pallio G, Minutoli L, Bagnato G, Anastasi GP, Mazzon E, Bramanti P, Squadrito F, Altavilla D and Bitto A (2018). Front. Pharmacol. 9:506. doi: 10.3389/fphar.2018.00506
In the published article, the Conflict of interest statement was incorrect. The correct Conflict of interest statement appears below:
Conflict of interest
“The author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB and DA are co-inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease. Author LM, FS and AB are co-inventor on a patent describing therapeutic polydeoxyribonucleotide activity in testicular injury by torsion.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest”.
The authors apologize for this error and state that this does not change the scientific conclusion of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: adenosine receptors, inflammation, neurogenesis, polydeoxyribonucleotide, spinal cord injury
Citation: Irrera N, Arcoraci V, Mannino F, Vermiglio G, Pallio G, Minutoli L, Bagnato G, Anastasi GP, Mazzon E, Bramanti P, Squadrito F, Altavilla D and Bitto A (2022) Corrigendum: Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury. Front. Pharmacol. 13:1073726. doi: 10.3389/fphar.2022.1073726
Received: 18 October 2022; Accepted: 03 November 2022;
Published: 03 November 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Irrera, Arcoraci, Mannino, Vermiglio, Pallio, Minutoli, Bagnato, Anastasi, Mazzon, Bramanti, Squadrito, Altavilla and Bitto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Francesco Squadrito, ZnNxdWFkcml0b0B1bmltZS5pdA==